Heart Failure after Ischemic Stroke or TIA in Insulin-Resistant Patients without Diabetes Treated with Pioglitazone

BACKGROUND: The Insulin Resistance Intervention after Stroke (IRIS) trial demonstrated that pioglitazone reduced risk for both cardiovascular events and diabetes in insulin resistant patients. However, concern remains that pioglitazone may increase risk for heart failure (HF) in susceptible individu...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Circulation
Hoofdauteurs: Young, Lawrence H., Viscoli, Catherine M., Schwartz, Gregory G., Inzucchi, Silvio E., Curtis, Jeptha P., Gorman, Mark J., Furie, Karen L., Conwit, Robin, Spatz, Erica, Lovejoy, Anne, Abbott, J. Dawn, Jacoby, Daniel L., Kolansky, Daniel M., Ling, Frederick S., Pfau, Steven E., Kernan, Walter N.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2018
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6202153/
https://ncbi.nlm.nih.gov/pubmed/29934374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.118.034763
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items